BioSpace News Archive

Business

Incyte Reports 2019 First Quarter Financial Results and Provides Updates on Key Clinical Programs

Total revenues of $498 million (+30% vs Q1 2018) and total product-related revenues of $458 million (+20% vs Q1 2018) for the quarter ended March 31, 2019

April 30, 2019
·
22 min read
BioMidwest

AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson’s Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting

Presentations include updates on ABBV-951, a subcutaneous infusion therapy for Parkinson’s disease (PD), and elezanumab, a monoclonal antibody directed against repulsive guidance molecule A (RGMa) in multiple sclerosis (MS), among other data to be presented

April 30, 2019
·
5 min read
Deals

Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update

Rigel Pharmaceuticals, Inc. announced that it will report its first quarter 2019 financial results after market close on Tuesday, May 7, 2019.

April 30, 2019
·
1 min read
Deals

Aerie Pharmaceuticals to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019

Aerie Pharmaceuticals, Inc. announced that its first quarter 2019 financial results will be released after the market closes on Tuesday, May 7, 2019.

April 30, 2019
·
3 min read
Business

Adicet Bio Appoints Anil Singhal Chief Executive Officer

Adicet Bio, Inc. announced that the Board of Directors has appointed Anil Singhal, Ph.D., MBA, President and Chief Executive Officer, effective May 6, 2019.

April 30, 2019
·
3 min read
FDA

Phoenix Tissue Repair Receives FDA Fast Track Designation for PTR-01 for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) and Provides Updates on the Phase 1/2 Clinical Study

Phoenix Tissue Repair, Inc. announced that the U.S. Food and Drug Administration has granted fast track designation for PTR-01, an investigational protein replacement therapy designed to treat recessive dystrophic epidermolysis bullosa.

April 30, 2019
·
5 min read
Lifestyle Delivery Systems Inc. Announces CannaStrips™ Presenting at The Hall of Flowers Event

Lifestyle Delivery Systems Inc., announces its flagship product, CannaStripsTM, will be presented at the Hall of Flowers premium cannabis brands trade show.

April 30, 2019
·
3 min read
Biotech Bay

Eiger to Present at ChinaBio® Partnering Forum 2019

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will participate and present a corporate update at the ChinaBio® Partnering Forum 2019 on May 8 in Shanghai, China.

April 30, 2019
·
1 min read
Deals

Evogene Files Annual Report for the Year Ended December 31, 2018

Evogene Ltd. announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with the U.S. Securities and Exchange Commission.

April 30, 2019
·
2 min read
Deals

REGENXBIO to Host Conference Call on May 7 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights

REGENXBIO Inc. announced that it will host a conference call on Tuesday, May 7, 2019, at 4:30 p.m. ET to discuss its financial results for the quarter ended March 31, 2019, and recent operational highlights.

April 30, 2019
·
1 min read